Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Super Bowl of Mismanaging Congressional Investigations: Shkreli Vs. Valeant

This article was originally published in RPM Report

Executive Summary

Which is stupider: Smirking, pleading the Fifth and then calling a Congressional Committee “imbeciles” on Twitter? Or spending four hours apologizing for excessive price increases and then running two DTC commercials during the Super Bowl?

You may also be interested in...



Drug Pricing ‘Biggest Offenders’ Are Annual Increases On Widely Used Brands

Express Scripts Chief Medical Officer Steve Miller suggests that caps on annual price increases could significantly ease payer concerns over drug pricing.

Hospital Inpatient Drug Spending Up 23%, Driven By Price Increases

Older drugs and high-volume drugs contributed substantially to the increases, study conducted on behalf of hospital trade groups finds.

At Drug Pricing Hearing, Innovator Companies Mainly Escape Congressional Wrath

Members of House Oversight Committee accuse Turing and Valeant of 'trashing' mainstream innovator companies with their drug pricing practices.

Topics

Related Companies

UsernamePublicRestriction

Register

PS079904

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel